Clik here to view.
BEXAGLIFLOZIN
Bexagliflozin THR1442; THR-1442, EGT 0001442; EGT1442 CAS :1118567-05-7 (2S,3R,4R,5S,6R)-2-[4-chloro-3-({4-[2- (cyclopropyloxy) ethoxy] phenyl} methyl)phenyl]-6-(hydroxymethyl)tetrahydro-2H-...
View ArticleClik here to view.
GKM 001 in pipeline for Diabetes by Advinus
GKM 001……Several probables Watch out on this post as I get to correct structure……….. Advinus Therapeutics Private L, A glucokinase activator for treatment of type II diabetes Company Advinus...
View ArticleClik here to view.
ZYDPLA 1 From Zydus Cadila, a New NCE in Gliptin class of Antidiabetic agents.
GENERAL STRUCTURE ZYDPLA 1……….Probable Representative structure only, I will modify it as per available info Watch out on this post as I get to correct structure……….. Cadila Healthcare Limited...
View ArticleClik here to view.
Zydus Cadila’s new 2-phenyl-5-heterocyclyl-tetrahydro-2h-pyran-3-amine...
List of compounds as DPP-IV inhibitors Watch out on this post as I get to correct structure……….. 2-phenyl-5-heterocyclyl-tetrahydro-2h-pyran-3-amine compounds One Example of...
View ArticleClik here to view.
Experimental Study on Holoptelia Integrifolia Planch. in Relation to Diabetes...
Holoptelia integrifolia (Chirabilva) Experimental Study on Holoptelia Integrifolia in Relation to Diabetes Mellitus Type 2 International Journal of Pharma Research &Review,Sept2015; 4(9):21-25...
View ArticleClik here to view.
MELOGLIPTIN
Melogliptin Phase III A DP-IV inhibitor potentially for treatment of type II diabetes. EMD-675992; GRC-8200 CAS No. 868771-57-7...
View ArticleClik here to view.
Novartis Molecule for functionally liver selective glucokinase activators for...
2 (R)-3-Cyclopentyl-N-(5-methoxy-thiazolo[5,4-b]pyridin-2-yl)-2-[4-(4-methyl-piperazine-1-sulfonyl)-phenyl]-propionamide...
View ArticleClik here to view.
Novartis, Torrent drug for diabetes, NVP-LBX192, LBX-192
(R)-3-Cyclopentyl-N-(5-methoxy-thiazolo[5,4-b]pyridin-2-yl)-2-[4-(4-methyl-piperazine-1-sulfonyl)-phenyl]-propionamide...
View ArticleClik here to view.
FDA approves Admelog, the first short-acting “follow-on” insulin product to...
FDA approves Admelog, the first short-acting “follow-on” insulin product to treat diabetes The U.S. Food and Drug Administration today approved Admelog (insulin lispro injection), a short-acting...
View ArticleClik here to view.
BMS-986118, for treatment for type 2 diabetes( GPR40 agonists with a dual...
BMS-986118 BMS compd for treatment for type 2 diabetes( GPR40 agonists with a dual mechanism of action, promoting both glucose-dependent insulin and incretin secretion) Cas 1610562-74-7...
View ArticleClik here to view.
SRT 1720
SRT-1720 diHCl CAY10559 CAS: 1001645-58-4 (di HCl) , 925434-55-5 (free base) 1001645-58-4 (HCl) Chemical Formula: C25H25Cl2N7OS Molecular Weight: 542.483 Elemental Analysis: C, 55.35; H, 4.65; Cl,...
View ArticleClik here to view.
ACLIMOSTAT
Aclimostat CAS: 2082752-83-6 Chemical Formula: C26H42N2O6 Molecular Weight: 478.63 Elemental Analysis: C, 65.25; H, 8.85; N, 5.85; O, 20.06 ZGN-1061; ZGN1061; ZGN 1061; Aclimostat, UNII-X150A3JK8R...
View ArticleFDA approves new treatment Victoza (liraglutide) for pediatric patients with...
The U.S. Food and Drug Administration today approved Victoza (liraglutide) injection for treatment of pediatric patients 10 years or older with type 2 diabetes. Victoza is the first non-insulin drug...
View ArticleClik here to view.
SY-008
SY-008 CAS 1878218-66-6 FREE FORM 1480443-32-0 SGLT1 inhibitor (type 2 diabetes), β-D-Glucopyranoside,...
View ArticleGLUCAGON
glucagon EMA……Ogluo (glucagon), a hybrid medicine for the treatment of severe hypoglycaemia in diabetes mellitus. Hybrid applications rely in part on the results of pre-clinical tests and clinical...
View ArticleClik here to view.
Meglimin hydrochloride
Meglimin hydrochloride Twymeeg Formula C6H13N5. HCl CAS 775351-61-6 (HCl). , C6H14ClN5 191.66CAS 775351-65-0, FREEFORM 155.20 Mol weight 191.6619 AntidiabeticAPPROVED PMDA JAPAN2021/6/23, イメグリミン塩酸塩...
View Article